glp-1 medication insurance coverage of Obesity Therapies in State-Regulated Markets Medicare covers GLP-1s for $50/month

Tirzepatide vs Semaglutide head-to-head (SURMOUNT-5)

GLP-1 mimics incretin, a gut hormone that aids in digestion and blood glucose control, essentially helping the body feel full

The exciting beyond obesity frontier for GLP-1 drugs is their potential to treat conditions where inflammation, or other non-obesity factors, are the primary cause

From reducing inflammation and stabilizing blood sugar to improving sleep, alcohol choices, and recovery habits, these simple strategies are especially valuable for anyone navigating thyroid issues, autoimmune conditions, or metabolic challenges

Exceeding benchmarks (e.g

Theyre associated with a lower risk of several cancers, including pancreatic cancer and multiple myeloma